GlassScriptPhysician profile
Robert Bruno Preli
NPI 1285656595
$11,784.56
in general payments reported to CMS, 2019-2025
33 companies · $2,074 in 2025
The $2,074 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $1,112 · 2021: $1,645 · 2022: $2,055 · 2023: $1,503 · 2024: $2,459 · 2025: $2,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,148 · Travel and Lodging: $1,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,147.96 |
| Travel and Lodging | $1,888.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,449.02 | 2019-2025 | Triclip, Amplatzer Talisman, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,175.78 | 2019-2025 | |
| Abiomed | $884.20 | 2019-2025 | Impella |
| Amgen INC. | $741.97 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $671.52 | 2019-2025 | Wainua, Lokelma, Brilinta |
| Janssen Pharmaceuticals, INC | $631.77 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $588.04 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $503.31 | 2020-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $469.85 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $444.30 | 2019-2025 | Watchman Access System, Ekosonic, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $297.94 | 2019-2022 | |
| Cvrx, INC. | $229.69 | 2022-2024 | Barostim Neo System |
| Atricure, INC. | $223.64 | 2022-2024 | |
| Novo Nordisk INC | $196.91 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Inari Medical, INC. | $170.20 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $169.54 | 2021 | |
| Philips North America LLC | $168.07 | 2024 | (Ck4) Mcot, (Br0) Coronary Atherectomy |
| Medtronic, INC. | $154.65 | 2021-2025 | Micra, Symplicity G3, Onyx Frontier |
| Cardiva Medical, INC. | $103.51 | 2021-2025 | Optowire, Savvywire |
| Vital Connect, INC | $102.81 | 2023-2025 | Vitalpatch Rtm |
| Biosense Webster, INC. | $82.31 | 2022-2025 | Nuvision Ice Catheter, Qdot Micro, Carto 3 |
| Pfizer INC. | $59.97 | 2020-2023 | |
| Medtronic Vascular, INC. | $52.49 | 2019 | |
| Chiesi USA, INC. | $35.68 | 2024-2025 | Kengreal |
| Otsuka America Pharmaceutical, INC. | $34.81 | 2019 | |
| Terumo Medical Corporation | $30.62 | 2021-2023 | Glidewire |
| Siemens Medical Solutions USA, INC. | $19.99 | 2025 | Artis Pheno |
| Biotronik INC. | $18.41 | 2025 | Biomonitor |
| Artivion, INC. | $17.81 | 2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Bioglue Surgical Adhesive |
| Alnylam Pharmaceuticals INC. | $16.04 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $14.30 | 2025 | Attruby |
| Portola Pharmaceuticals, LLC | $13.82 | 2019 | |
| Medicure Pharma INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Preli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.